Expanse Medical announced an expansion to Rhode Island with support from the Rhode Island Life Science Hub (RILSH). Expanse will establish a facility in Providence to accelerate East Coast partnerships and launch its newest portfolio company, Valorian Medical Technologies, dedicated to men's health.
"We are excited to join Rhode Island's growing life sciences ecosystem and expand our venture building model," said Eitan Konstantino, PhD, founder and CEO of Expanse. "This new base enables us to collaborate with East Coast innovators to imagine what's next and build it."
Valorian Medical Technologies will leverage Expanse's full-cycle product development and clinical capabilities. Its formation follows the successful launch of FlowPhysix, Expanse's Austin, Texas based portfolio company whose FDA cleared FLOWRUNNER Aspiration System is being commercialized nationwide for treatment of blood clots.
"We are proud to support Expanse as they bring transformative capabilities and new ventures to Rhode Island," said Mark A. Turco, MD, President and CEO of RILSH. "The company's decision to grow here reflects Rhode Island's momentum as a destination for high-growth life science companies. Expanse exemplifies the kind of entrepreneurial and technical excellence we aim to foster as we build a nationally recognized innovation hub for life sciences. It also brings deep engineering expertise and a proven venture-building model that will add real depth to our medtech community."
The Providence facility will serve as innovation hub and launchpad for medical device ventures, connecting engineering talent, clinicians, and investors while contributing to Rhode Island's emergence as a life sciences cluster.
